The relationship between metabolic disorders and heart disease is well-established, with conditions like insulin resistance, metabolic syndrome, and obesity playing major roles in the development of cardiovascular diseases. These systemic heart diseases often complicate the management of heart conditions, requiring tailored treatment strategies that address both the metabolic and cardiac aspects. Interventions such as weight management, glucose control, and the use of medications that target metabolic pathways can help reduce the burden of these diseases on the heart. With early detection and proper management, it is possible to prevent the progression of metabolic and systemic heart diseases, ultimately improving patient outcomes and reducing the risk of severe cardiovascular events.
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Precision nutrition for heart health: A personalized approach to cardiovascular disease prevention and management
Teji Dhami, BOOST your Health and Wellness, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain